The cushion is gone, and what comes next is not a temporary dip.
Across a continent of 1.5 billion people, the architecture of borrowed health security is giving way. International donor funding to Africa has been halved in five years — from $26 billion to $13 billion — even as disease outbreaks multiply and a new Ebola strain emerges without vaccine or cure. African leaders are now confronting a question long deferred: whether a people can truly be well when their medicines, their vaccines, and their emergency response all depend on the goodwill of others. The pursuit of 'health sovereignty' is, at its core, a reckoning with that dependency — and with the distance between the promises nations make to their own people and the systems they actually build.
- A new Ebola strain with no approved vaccine or treatment has emerged in Congo and Uganda precisely as the continent's external health funding collapses to half its 2021 levels.
- Disease emergencies across Africa surged from 153 outbreaks in 2022 to 242 in 2024, while only three of 54 nations meet their own decade-old pledge to spend 15% of budgets on health.
- African leaders have launched concrete sovereignty initiatives — sin taxes, pooled medicine procurement, local vaccine manufacturing — but the continent still imports 90% of its vaccines and medicines, leaving populations exposed.
- The Trump administration is conditioning remaining U.S. health aid on co-financing agreements and data-sharing, which critics call unrealistic for nations where 40% already spend more on debt service than on health.
- With $1.2 trillion in total debt and $40 billion lost annually to illicit financial flows in extractive industries, the resources theoretically available for health sovereignty are being drained before they can be mobilized.
In Harare and across the continent, health officials are confronting a hard truth that can no longer be deferred: the external funding that once contained Africa's disease outbreaks has been cut in half. Official development assistance fell from $26 billion in 2021 to roughly $13 billion in 2025, even as a new Ebola strain — one without an approved vaccine or treatment — has emerged in Congo and Uganda. Dr. Jean Kaseya of the Africa CDC has been direct: when outbreaks strike, governments scramble for partners because their own budgets hold nothing in reserve. Wealthy nations have turned their attention elsewhere, and the safety net is simply gone.
The collapse has exposed a structural failure decades in the making. In 2001, African nations pledged to spend at least 15 percent of national budgets on health. Today, only Rwanda, Botswana, and Cape Verde are on track to honor that commitment. The donor system had masked the gap — until now. Between 2022 and 2024, health emergencies surged from 153 outbreaks to 242. The continent imports more than 90 percent of its vaccines and medicines. Health financing expert Dr. Alex Ajangba was unsparing: this is not a temporary dip from which recovery will come.
The response taking shape is called 'health sovereignty' — a turn toward domestic financing, local pharmaceutical manufacturing, pooled procurement, and taxes on tobacco, alcohol, and sugary drinks. The Africa CDC has set a target of producing 60 percent of vaccines locally by 2040. Lower-income nations contributed a record $302 million toward vaccines in 2025, and Gavi's chief executive Sania Nishtar argues that co-financing creates the kind of predictability that aid dependency never could.
Yet the path is treacherous. Africa holds roughly 30 percent of the world's mineral reserves, but loses an estimated $40 billion annually to illicit financial flows in extractive industries — wealth that evaporates before it can fund public health. Approximately 40 percent of African countries now spend more servicing debt than investing in health, with debt consuming nearly 19 percent of sub-Saharan government revenue. Into this strain, the Trump administration has introduced co-financing conditions tied to data-sharing and natural resource exchanges, which critics say set struggling economies up to fail. 'When an administration says if you don't hit these numbers you won't get resources,' warned Health GAP's Asia Russell, 'that is extremely serious.' The people who will feel the consequences most acutely are those waiting, during the next outbreak, for medicines that may not arrive.
In Harare, Zimbabwe, health officials are confronting a hard truth: the money that once kept African disease outbreaks contained is running out. A new Ebola strain has emerged in Congo and Uganda—one for which no vaccine or approved treatment exists—arriving at a moment when the continent's international health funding has been cut in half over five years. Official development assistance to Africa dropped from $26 billion in 2021 to roughly $13 billion in 2025, a collapse that coincides with surging disease emergencies and a population now exceeding 1.5 billion people.
Dr. Jean Kaseya, director-general of the Africa Centers for Disease Control and Prevention, has begun speaking plainly about what this means. When outbreaks occur, he explained, countries scramble to find partners because their own budgets contain no money to respond—let alone prepare. The continent now faces what the Africa CDC calls an "unprecedented financing crisis." Wealthy nations have turned their attention elsewhere: geopolitical tensions, domestic concerns, the war in Iran. The safety net that once existed is simply gone.
For decades, African governments made promises they could not keep. In 2001, nations committed to spending at least 15 percent of their national budgets on health. Today, only three countries—Rwanda, Botswana, and Cape Verde—are on track to meet that pledge out of Africa's 54 nations. The gap between aspiration and reality widened because the donor system still functioned, masking the underlying weakness. Dr. Alex Ajangba, a health financing expert, put it plainly: "What we are seeing here is not a temporary dip of donor funding that we will recover from." The cushion is gone.
African leaders are now pursuing what they call "health sovereignty"—a shift toward financing and managing their own health systems with minimal external aid. Ghana launched its "Accra Reset" in September. In February, African leaders adopted the Africa Health Security and Sovereignty Agenda. The proposals are concrete: higher taxes on tobacco, alcohol, and sugary drinks; pooled purchasing of medicines to drive down costs; expansion of local pharmaceutical and vaccine manufacturing; elimination of waste. The need is stark. Africa imports more than 90 percent of its vaccines and medicines. Between 2022 and 2024, health emergencies on the continent surged from 153 outbreaks to 242. The Africa CDC has set a target: 60 percent of vaccines produced locally by 2040.
Yet the phrase "health sovereignty" risks becoming merely a slogan, Ajangba warned. The continent possesses roughly 30 percent of the world's mineral reserves—resources essential for technology and renewable energy—but much of that wealth vanishes through weak contracts, illicit financial flows, and the export of raw materials with minimal local processing. Africa loses approximately $40 billion annually to illicit financial flows in extractive industries. Another strategy gaining traction is co-financing, in which countries contribute alongside donors. Lower-income nations contributed a record $302 million toward vaccines in 2025, and roughly $1 billion over the past five years, according to Gavi, the global vaccine alliance. This creates predictability, said Gavi's chief executive Sania Nishtar—something that reliance on aid does not.
But the transition is becoming contentious. The Trump administration has made co-financing a condition of its "America First" health deals with nearly two dozen African nations, requiring countries to increase domestic spending within specified timeframes or lose support. Some nations have rejected these proposals, objecting to U.S. requests for health data sharing with no guarantee of benefit, or to proposed exchanges of health support for natural resources. Critics argue the conditions are unrealistic for economies already straining under debt. "They are being set up to fail," said Asia Russell, executive director of Health GAP, an international advocacy group. "When an administration says, 'If you don't hit these numbers, you're not going to get resources anymore,' that is extremely serious."
Debt itself is squeezing health spending across the continent. About 40 percent of African countries now spend more on servicing debt than on health. Africa's total debt has surged to approximately $1.2 trillion. Debt servicing consumes roughly 19 percent of government revenue in sub-Saharan African countries, according to the United Nations. The trade-offs are brutal. As one health policy expert noted, it will be the people living in these countries who ultimately feel the effects—when outbreaks come and the medicines are not there.
Citações Notáveis
Every time we have an outbreak, many countries start to ask for partners because they don't have in their budgets funding to respond, even to prepare for these outbreaks.— Dr. Jean Kaseya, director-general of the Africa Centers for Disease Control and Prevention
What we are seeing here is not a temporary dip of donor funding that we will recover from.— Dr. Alex Ajangba, health financing expert
A Conversa do Hearth Outra perspectiva sobre a história
Why is this moment different from previous health crises on the continent?
Because the donor system that masked the underlying problem has finally broken. For years, when an outbreak happened, countries could call their partners. Now that call goes unanswered. The money is simply not there.
So "health sovereignty" is born from necessity, not choice?
Exactly. It's not ideological. It's what happens when the alternative—waiting for external support—becomes impossible. But the danger is that it becomes a catchphrase without real resources behind it.
Africa has mineral wealth. Why can't that wealth translate into health spending?
Because most of it leaves the continent as raw material. A mine produces ore; the ore is shipped out; the profit goes elsewhere. Weak contracts, corruption, illicit flows—these drain roughly $40 billion a year. The wealth is there, but the mechanisms to capture and redirect it are broken.
What about the U.S. conditions on aid?
They're a double bind. On one hand, yes, countries need to spend more of their own money. On the other hand, telling a country drowning in debt that it must increase health spending or lose aid is asking it to do the impossible. The timing is cruel.
Is there any path forward that doesn't end in failure?
Only if African nations can simultaneously tackle debt, plug illicit financial flows, build local manufacturing capacity, and increase domestic taxation—all while managing active disease outbreaks. It's theoretically possible. But the window is narrow, and the pressure is immense.